ICS 2013 Scientific Podium Poster Session S13 - LUTS in Women 1

LUTS in Women 1

Scientific Podium Poster Session S13

Speakers
	Wednesday 28th August 2013
	16:00 - 17:30
	116 Capacity: 350
E Emmanuel Jean Chartier-Kastler ICS Chair T Tufan Tarcan ICS Chair

Summary by Tufan Tarcan

I had the privilege to chair the session “LUTS in Women 1” with Dr. Emmanuel Chartier-Kastler. Three with outstanding information among all valuable 11 posters are highlighted below.

Firstly, Dr. Nitti presented data on the long-term efficacy and safety of onabotulinumtoxin A treatment of refractory wet OAB. In an interim analysis of an ongoing extension study of the phase 3 trials reductions in UI episodes and improved Q&L over 5 treatment cycles were demonstrated with no new safety signals.

In another study, Dr. Elneil presented their experience on two-stage sacral neuromodulation for chronic urinary retention in 169 women where about one-third had Fowler’s syndrome. The success rate of the first stage was sustained at the second stage in 94% of patients at 12 months follow-up, irrespective of aetiology.

And lastly, Dr. Brubaker reported that bladder microbiota in women who were free of clinical urinary tract infection differ among different UI subtypes (urgency vs stress) suggesting that differing components or entire bacterial communities could affect urgency UI symptoms.

Session Schedule

16:30

#119 Clinically Meaningful Improvements in Urinary Incontinence and Quality of Life Over Multiple Treatment Cycles of OnabotulinumtoxinA in Patients with Overactive Bladder Syndrome and Urinary Incontinence: Interim Analysis of a Long-term Extension Study

Presenter: Victor Nitti

Nitti V¹, Sievert K², Chapple C³, Sussman D⁴, Radomski S⁵, Sand P⁶, Thompson C⁷, Nardo C⁸, Zhou J⁸, Globe D⁸, Haag-Molkenteller C⁸
1. New York University School of Medicine, 2. University of Tuebingen, 3. Royal Hallamshire Hospital, 4. New Jersey School of Osteopathic Medicine, 5. University of Toronto, 6. University of Chicago, 7. Allergan, Ltd., 8. Allergan, Inc.
Overactive Bladder, Incontinence, Quality of Life (QoL), Detrusor Overactivity

16:35

#120 A prospective randomised controlled multicentre trial comparing intravesical DMSO and chondroitin sulphate 2 for painful bladder syndrome /interstitial cystitis

Presenter: Dirk De Ridder

De Ridder D¹, Klockaerts K², Plancke H³, Ost D⁴, Van der Aa F¹
1. Urology, University Hospitals KU Leuven, Belgium, 2. Urology, St. Lucas Hospital, Gent, Belgium, 3. Urology, Imelda Hospital, Bonheiden, Belgium, 4. Urology, St. Blasius Hospital, Dendermonde, Belgium
Pain, Pelvic/Perineal, Clinical Trial, Painful Bladder Syndrome/Interstitial Cystitis (IC), Prospective Study

16:40

#121 The relationship between the urine NOx and the serum NOx in the women with OAB in community-based study

Presenter: Hisashi Honjo

Honjo H¹, Naya Y², Nakao M³, Ueyama J⁴, Kondo T⁴, Nakanishi M², Ukimura O⁵, Kawauchi A², Miki T²
1. Meiji University of Integrative Medicine and Kyoto Prefectural University of Medicine, 2. Kyoto Prefectural University of Medicine, 3. Meiji University of Integrative Medicine, 4. Nagoya University Graduate School of Medicine, 5. University of Southern California and Kyoto Prefectural University of Medicine
Overactive Bladder, Incontinence, Urgency Urinary Incontinence

16:45

#122 A MICROBIOLOGICAL ASSESSMENT OF THE ROUTINE MIDSTREAM URINE CULTURE TO IDENTIFY URINARY TRACT INFECTION IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS.

Presenter: Sanchutha Sathiananthamoorthy

Sathiananthamoorthy S¹, Gill K¹, Swamy S¹, Kupelian A¹, Collins L², Malone-Lee J¹
1. University College London (UCL), UK, 2. University of Southamptom, UK
Infection, Urinary Tract, Basic Science, Female

16:50

#123 Bacteria in the bladder wall of women with lower urinary tract symptoms:an interesting finding

Presenter: Gopalan Vijaya

Vijaya G¹, Dutta S¹, Singh A U¹, Bray R¹, Digesu A¹, Fernando R¹, Khullar V¹
1. st.mary's hospital,Imperial college ,London
Infection, Urinary Tract, Overactive Bladder, Female

16:55

#124 Are we justified in the dismissing microscopic pyuria of 1-9 wbc µl-1 as normal in symptomatic patients?

Presenter: Kiren Gill

Gill K¹, Horsley H¹, Kupelian A S¹, Sathiananthamoorthy S¹, Swamy S¹, Collins L¹, Rohn J L¹, Malone-Lee J¹
1. University College London, UK
Incontinence, Infection, Urinary Tract, Basic Science, Overactive Bladder, Urgency/Frequency

17:00

#125 A negative association between uncomplicated cystitis in women and wiping method of the vulva after bowel movements

Presenter: Saya Ikoma

Ikoma S¹, Noguchi M¹, Tobu S¹, Nanri M², Yokoo D³, Takagi N⁴, Nakamura K⁵, Uozumi J¹
1. Department of Urology, Faculty of Medicine, Saga University, 2. Nanri Urological Hospital, 3. Yokoo Clinic, 4. Department of Urology, National Hospital Organization Saga National Hospital, 5. Department of Urology, Fujisaki Hospital
Female, Infection, Urinary Tract

17:05

#126 Is “asymptomatic” bacteriuria always asymptomatic? Associations between individual female lower urinary tract symptoms and sub-clinical bacterial infection in random urine samples

Presenter: Felice Sorrentino

Sorrentino F¹, Tolton L², Cartwright R³, Pass D¹, Franklin L⁴, Greco P⁵, Khullar V¹, Digesu A¹
1. Dept of Urogynaecology, St Mary's Hospital, London, UK, 2. Reproductive & Developmental Biology, Imperial College London, UK, 3. Dept of Epidemiology & Biostatistics, Imperial College London, 4. Women's Health Research Centre, Imperial College London, UK, 5. Dept of Obstetrics and Gynaecology, University of Foggia, Italy
Infection, Urinary Tract, Overactive Bladder, Painful Bladder Syndrome/Interstitial Cystitis (IC), Female, Questionnaire

17:10

#127 The time since the diagnosis of diabetes might be linked to lower urinary tract symptoms

Presenter: Yuan-Mei Liao

Liao Y¹, Li C², Chang L¹, Chang C³, Chang C⁴, Pei D⁵
1. Graduate Institute of Nursing, College of Nursing, Taipei Medical University, 2. Department of Surgery, Cardinal Tien Hospital, 3. School of Gerontology Health Management, College of Nursing,Taipei Medical University, 4. Department of Endocrinology, Taipei Medical University WanFang Hospital, 5. Department of Endocrinology, Cardinal Tien Hospital
Female, Quality of Life (QoL), Voiding Dysfunction

17:15

#128 Two-stage sacral neuromodulation for chronic urinary retention in women: determination of prognostic factors that may affect outcome

Presenter: Sohier Elneil

Elneil S¹, Abtahi B¹, Helal M¹, Khan S¹, Gonzales G¹
1. Institue of Neurology, National Hospital for Neurology and Neurosurgery
Female, Voiding Dysfunction , Neuromodulation

17:20

#129 Autoplastic closure of complex vesicovaginal fistula with posterosuperior bladder flap: a 27-year experience.

Presenter: Enrique Rijo

Rijo E¹, Bielsa O¹, Lorente J A¹, Gil-Vernet J M², Francés A¹, Fumadó L¹, Nohales G¹, Arango O¹
1. Department of Urology, Universitat Autònoma de Barcelona, Hospital del Mar, Barcelona, Spain, 2. Centro Medico Teknon, Barcelona, Spain
Female, Fistulas, Retrospective Study, Surgery

17:25

#130 Preliminary Evidence of Urinary Microbiome's Role in Female Urinary Incontinence Subtypes

Presenter: Linda Brubaker

Brubaker L¹, Fok C¹, Zilliox M², Rosenfeld A², Pearce M², Mueller E¹, Kenton K¹, Gai X², Wolfe A²
1. Loyola University Medical Center - Dept. OB-Gyne, Female Pelvic Medicine & Reconstructive Surgery, 2. Loyola University, Chicago
Female, Stress Urinary Incontinence, Urgency Urinary Incontinence